Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Cash & Current Investments (2016 - 2025)

Nutex Health's Cash & Current Investments history spans 16 years, with the latest figure at $185.9 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 357.36% year-over-year to $185.9 million; the TTM value through Dec 2025 reached $185.9 million, up 357.36%, while the annual FY2025 figure was $185.9 million, 357.36% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $185.9 million at Nutex Health, up from $166.0 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $185.9 million in Q4 2025 and bottomed at $12.7 million in Q1 2022.
  • The 5-year median for Cash & Current Investments is $35.2 million (2021), against an average of $51.8 million.
  • The largest annual shift saw Cash & Current Investments skyrocketed 134014.16% in 2021 before it plummeted 35.77% in 2023.
  • A 5-year view of Cash & Current Investments shows it stood at $36.1 million in 2021, then decreased by 5.16% to $34.3 million in 2022, then tumbled by 35.77% to $22.0 million in 2023, then soared by 84.71% to $40.6 million in 2024, then surged by 357.36% to $185.9 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Cash & Current Investments are $185.9 million (Q4 2025), $166.0 million (Q3 2025), and $96.7 million (Q2 2025).